Nasdaq · CIK 0000811641
ICCC IMMUCELL CORP /DE/
Insider trading from SEC Form 4. Last filing Apr 16, 2026. Close $9.80 on Oct 9, 2026, +115% from the 52-week low and -16% from the high.
IMMUCELL CORP /DE/ (ICCC) has 15 SEC Form 4 filings on file from 7 insiders, the latest filed on Apr 16, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
4 open-market trades have been scored at ICCC. The newest: Boekhorst Paul Francis Olivier te (President and CEO) bought $32k of stock on Dec 3, 2025, filed Dec 4, 2025, scored 53 (moderate). The largest of the 4 shown: Boekhorst Paul Francis Olivier te (President and CEO) bought $49k on Dec 2, 2025, scored 48 (moderate). 2 insiders bought within 14 days of each other around Dec 3, 2025.
ICCC closed at $9.80 on Oct 9, 2026, 115% above its 52-week low and 16% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at IMMUCELL CORP /DE/, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | Boekhorst Paul Francis Olivier te President and CEO buy | $32k 6,030 shares | +163% | - | |
| 48Moderate | Boekhorst Paul Francis Olivier te President and CEO buy | $49k 9,785 shares | - | - | |
| 26Weak | David Scott Tomsche director buy | $16k 3,266 shares | +6% | - | |
| 23Weak | Bryan K. Gathagan director buy | $6,320 1,000 shares | - | - |
Transactions
Every row filed, 23 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | Gloria F Basse director | AGrant or award Non Qualified Stock Options (Right to buy)derivative | +11,933 | $0.00 | $0 | 11,933 | Apr 16, 2026 |
| Apr 16, 2025 | Bobbi Jo Brockmann VP of Sales and Marketing | AGrant or award Incentive Stock Options (Right to buy)derivative | +5,000 | $0.00 | $0 | 5,000 | Apr 14, 2026 |
| Apr 16, 2025 | Gloria F Basse director | AGrant or award Non Qualified Stock Options (Right to buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Apr 14, 2026 |
| Mar 20, 2026 | Michael F Brigham director | MOption exercise Common Stock, par value $.01 per share | +25,000 | $5.84 | $146k | 229,752 | Mar 24, 2026 |
| Mar 20, 2026 | Michael F Brigham director | FTax withholding Common Stock, par value $.01 per share | -24,052 | $6.07 | $146k | 205,700 | Mar 24, 2026 |
| Mar 20, 2026 | Michael F Brigham director | MOption exercise Stock Options (right to buy)derivative | -25,000 | $0.00 | $0 | 0 | Mar 24, 2026 |
| Jan 27, 2026 | Boekhorst Paul Francis Olivier te President and CEO | AGrant or award Stock Options (right to buy)derivative | +109,500 | $0.00 | $0 | 109,500 | Mar 23, 2026 |
| Jan 27, 2026 | Timothy C Fiori Chief Financial Officer | AGrant or award Stock Options (right to buy)derivative | +120,000 | $0.00 | $0 | 120,000 | Jan 29, 2026 |
| Jan 27, 2026 | Boekhorst Paul Francis Olivier te President and CEO | AGrant or award Stock Options (right to buy)derivative | +110,000 | $0.00 | $0 | 110,000 | Jan 29, 2026 |
| Jan 27, 2026 | Bobbi Jo Brockmann VP of Sales and Marketing | AGrant or award Stock Options (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Jan 29, 2026 |
| Dec 3, 2025 | Boekhorst Paul Francis Olivier te President and CEO | POpen-market purchase Common Stock $0.10 par value per share | +3,598 | $5.05 | $18k | 7,306 | Dec 4, 2025 |
| Dec 4, 2025 | Boekhorst Paul Francis Olivier te President and CEO | POpen-market purchase Common Stock $0.10 par value per share | +2,432 | $5.50 | $13k | 9,738 | Dec 4, 2025 |
| Dec 2, 2025 | Boekhorst Paul Francis Olivier te President and CEO | POpen-market purchase Common Stock $0.10 par value per share | +3,708 | $4.87 | $18k | 3,708 | Dec 3, 2025 |
| Dec 3, 2025 | Boekhorst Paul Francis Olivier te President and CEO | POpen-market purchase Common Stock $0.10 par value per share | +2,556 | $5.00 | $13k | 6,264 | Dec 3, 2025 |
| Dec 3, 2025 | Boekhorst Paul Francis Olivier te President and CEO | POpen-market purchase Common Stock $0.10 par value per share | +3,521 | $5.04 | $18k | 9,785 | Dec 3, 2025 |
| Nov 25, 2025 | David Scott Tomsche director | POpen-market purchase Common Stock $0.10 par value per share | +1,633 | $4.76 | $7,773 | 52,720 | Nov 28, 2025 |
| Nov 25, 2025 | David Scott Tomsche director | POpen-market purchase Common Stock $0.10 par value per shareindirect: By Spouse | +1,633 | $4.77 | $7,781 | 4,740 | Nov 28, 2025 |
| Nov 7, 2025 | Boekhorst Paul Francis Olivier te President and CEO | AGrant or award Stock Options (right to buy)derivative | +74,277 | $6.10 | $453k | 150,260 | Nov 12, 2025 |
| Jun 11, 2025 | Gloria F Basse director | MOption exercise Common stock $0.10 per value per share | +3,530 | $4.81 | $17k | 3,530 | Jun 13, 2025 |
| Jun 11, 2025 | Gloria F Basse director | MOption exercise Non Qualified Stock Options (Right to buy)derivative | -11,470 | $0.00 | $0 | 3,530 | Jun 13, 2025 |
| Jun 11, 2025 | Gloria F Basse director | MOption exercise Non Qualified Stock Options (Right to buy)derivative | -4 | $0.00 | $0 | 0 | Jun 13, 2025 |
| Jun 12, 2025 | Bryan K. Gathagan director | POpen-market purchase Common stock $0.10 per value per share | +1,000 | $6.32 | $6,320 | 1,000 | Jun 12, 2025 |
| Apr 16, 2025 | Timothy C Fiori Chief Financial Officer | AGrant or award Incentive Stock Options (Right to buy)derivative | +30,000 | $5.49 | $165k | 30,000 | Apr 23, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Michael F Brighamdirector
- Gloria F Bassedirector
- Bobbi Jo BrockmannVP of Sales and Marketing
- Timothy C FioriChief Financial Officer
- Bryan K. Gathagandirector
- David Scott Tomschedirector
- Boekhorst Paul Francis Olivier tePresident and CEO
Questions about ICCC
Answered from the filings on this page, as of the latest one.
Are insiders buying ICCC?
No. In the last 90 days no insider at IMMUCELL CORP /DE/ bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade ICCC on the open market?
Boekhorst Paul Francis Olivier te (President and CEO) bought $32k of ICCC on Dec 3, 2025 and filed the Form 4 on Dec 4, 2025. InsiderTell scored 53 (moderate), with 2 insiders on the same side within 14 days.
How many insiders file Form 4 at IMMUCELL CORP /DE/?
7 people have filed a Form 4 at IMMUCELL CORP /DE/, among them Michael F Brigham (director), Gloria F Basse (director), Bobbi Jo Brockmann (VP of Sales and Marketing). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.